Genoptix.com
  • HOME
    • HEALTHCARE PROFESSIONALS
    • COMPASS®
    • CHART®
  • ABOUT GENOPTIX
    • WHO WE ARE
    • VISION & MISSION
    • LEADERSHIP TEAM
    • HEMEPATH TEAM
    • LICENSES
    • CONTACT US
  • TEST MENU
    • ALPHABETICAL ORDER
    • BY DISEASE STATE – HEME
    • BY DISEASE STATE – SOLID TUMORS
    • TECHNOLOGY
  • PATIENTS
    • DISEASE AREAS
    • GETTING TESTED
    • BILLING QUESTIONS
  • BILLING
    • CONTACT BILLING SPECIALIST
  • CAREERS
  • GENOPTIX ONLINE
  • SEARCH
  • Search
  • Menu

Genoptix and Bionano Genomics Announce Strategic Alliance

Frontpage Article
Read more
June 28, 2017/0 Comments/by Genoptix
https://genoptix.com/wp-content/uploads/2017/09/home_Immunohistochemistry_.jpg 198 251 Genoptix https://genoptix.com/wp-content/uploads/2018/12/Genoptix_Logo_Tagline_180x180.png Genoptix2017-06-28 08:00:132017-12-15 13:44:17Genoptix and Bionano Genomics Announce Strategic Alliance

Pages

  • ABOUT GENOPTIX
  • BILLING
  • CHART®
  • CHART®
  • COMPASS®
  • DISEASE AREAS
  • GENOPTIX ONLINE
  • GETTING TESTED
  • HEALTHCARE PROFESSIONALS
  • Home
  • JOBS_Executive Administrator
  • JOBS_Mailman
  • Legal
  • Lymphoplasmacytic lymphoma (LPL)
  • MEET YOUR DEDICATED MEDICAL EXPERTS
  • mrdx_kit_terms
  • PATIENT BILLING
  • PATIENTS
  • Pay My Bill
  • Philadelphia chromosome (Ph-like) acute lymphoblastic leukemia (ALL)
  • QUESTIONS FOR MY DOCTOR
  • TEST MENU
  • TEST MENU _ A _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ A _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ B _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ C _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ E _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ F _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ G _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ H _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ I _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ J _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ K _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ L _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ M _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ N _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ P _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ Q _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ R _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ S _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ SEARCH BY CONSULTATIVE SERVICES
  • TEST MENU _ SEARCH BY SOLID TUMOR DISEASES
  • TEST MENU _ SEARCH BY TECHNOLOGY
  • TEST MENU _ SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ T _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU _ U _SEARCH BY TEST NAME (ALPHABETICALLY)
  • TEST MENU – SEARCH BY HEMATOLOGICAL DISEASES
  • TEST MENU – SEARCH BY TEST NAME ALPHABETICALLY
  • TEST MENU: CNS Tumors (especially Gliomas)
  • TEST MENU: Esophageal Cancer
  • TEST MENU: Acute leukemia of ambiguous lineage
  • TEST MENU: Acute lymphoblastic leukemia (ALL)
  • TEST MENU: Acute myeloid leukemia (AML)
  • TEST MENU: Acute myeloid leukemia with myelodysplasia-related changes (AML with MRC)
  • TEST MENU: Acute myeloid leukemia with myelodysplasia-related changes (AML with MRC)
  • TEST MENU: Acute promyelocytic leukemia (APL)
  • TEST MENU: Adult T-cell leukemia/lymphoma (ATLL)
  • TEST MENU: Anaplastic Large-Cell Lymphoma (ALCL)
  • TEST MENU: Anaplastic T-cell lymphoma (ATCL)
  • TEST MENU: Angioimmunoblastic T-cell lymphoma (AITL)
  • TEST MENU: Aplastic Anemia
  • TEST MENU: Atypical Chronic Myelogeneous Leukemia (aCML)
  • TEST MENU: B lymphoblastic leukemia/lymphoma
  • TEST MENU: B Lymphoblastic Leukemia/Lymphoma
  • TEST MENU: B-cell Acute Lymphoblastic Leukemia (ALL)
  • TEST MENU: B-cell Non-Hodgkin Lymphomas (NHL)
  • TEST MENU: Breast Cancer
  • TEST MENU: Burkitt Lymphoma (BL)
  • TEST MENU: Chronic Eosinophilia Leukemia (CEL)
  • TEST MENU: Chronic Lymphocytic Leukemia (CLL)
  • TEST MENU: Chronic Myelogenous Leukemia (CML)
  • TEST MENU: Chronic Myelomonocytic Leukemia (CMML)
  • TEST MENU: Chronic Neutrophilic Leukemia (CNL)
  • TEST MENU: Clonal Cytopenias of Undetermined Significance (CCUS)
  • TEST MENU: Colorectal Cancer (CRC)
  • TEST MENU: Cutaneous T-cell Lymphoma (CTCL)
  • TEST MENU: Cytogenetics
  • TEST MENU: Diffuse Large B-cell Lymphoma (DLBCL)
  • TEST MENU: Double-hit Lymphoma (DHL)
  • TEST MENU: Essential thrombocythemia (ET)
  • TEST MENU: Flow Cytometry
  • TEST MENU: Follicular Lymphoma (FL)
  • TEST MENU: Gastric Cancer
  • TEST MENU: Hairy Cell Leukemia (HCL)
  • TEST MENU: Heme – Pathology/Morphology
  • TEST MENU: Heme Molecular
  • TEST MENU: Hepatosplenic T-cell Lymphoma (HSTCL)
  • TEST MENU: Histology
  • TEST MENU: Hodgkin Lymphoma
  • TEST MENU: Large Granular Lymphocytic Leukemia (LGL)
  • TEST MENU: Mantle Cell Lymphoma (MCL)
  • TEST MENU: Marginal Zone Lymphoma (MZL)
  • TEST MENU: Mature B-cell Neoplasms
  • TEST MENU: Melanoma
  • TEST MENU: Monoclonal gammopathy of undetermined significance (MGUS)
  • TEST MENU: Multiple Myeloma (MM)
  • TEST MENU: Mycosis Fungoides (MF)
  • TEST MENU: Myelodysplastic Syndrome (MDS)
  • TEST MENU: Myeloid/Lymphoid Neoplasms with Eosinophilia
  • TEST MENU: Myeloproliferative Neoplasms (MPN)
  • TEST MENU: NK/T-cell Lymphoma
  • TEST MENU: Non-Hodgkin Lymphoma (NHL)
  • TEST MENU: Non-Small Cell Lung Cancer (NSCLC)
  • TEST MENU: Other Solid Tumors
  • TEST MENU: Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • TEST MENU: Peripheral T-cell Lymphoma (PTCL)
  • TEST MENU: Polycythemia Vera (PV)
  • TEST MENU: Primary Myelofibrosis (PMF)
  • TEST MENU: Prostate Cancer
  • TEST MENU: Richter’s Syndrome (RS)
  • TEST MENU: Sézary Syndrome (SS)
  • TEST MENU: Small Lymphocytic Lymphoma (SLL)
  • TEST MENU: Solid Tumor – Cytogenetics
  • TEST MENU: Solid Tumor – Immunohistochemistry (IHC)
  • TEST MENU: Solid Tumor – Molecular
  • TEST MENU: T-cell Large Granular Lymphocytic Leukemia (T-LGL)
  • TEST MENU: T-cell Neoplasms
  • TEST MENU: T-cell Prolymphocytic Leukemia (T-PLL)
  • TEST MENU: Thyroid Cancer
  • TEST MENU: Triple-hit lymphoma (THL)
  • TEST MENU: Urinary Bladder Cancer
  • TEST MENU: Various Solid and Hematological Neoplasms
  • TEST MENU: Various, case dependent
  • TEST MENU: Various, Case Dependent
  • TEST RESULTS
  • TESTING OPTIONS

Categories

  • Frontpage Article
  • Images
  • News

Archive

  • December 2018
  • October 2018
  • September 2018
  • June 2018
  • March 2018
  • December 2017
  • July 2017
  • June 2017
  • March 2017

CONTACT US

Genoptix, a NeoGenomics Company
2131 Faraday Ave
Carlsbad, CA 92008
Phone: +1.760.268.6200
Fax: +1.760.268.6201

Client Services
Phone: +1.800.755.1605
Fax: +1.888.755.1604
Email: clientservices@genoptix.com

Medical Director: Derek Lyle, MD

Recent News

  • NeoGenomics Completes Acquisition of Genoptix, Inc.December 10, 2018 - 9:00 am
  • NeoGenomics Signs Definitive Agreement to Acquire GenoptixOctober 23, 2018 - 9:00 am
  • Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna® (nilotinib)September 4, 2018 - 8:30 am

HOURS OF OPERATION

Our lab is open six days a week:
5:00am to 6:00pm PT Mon-Fri
7:00am to 3:30pm PT Saturday

For after-hours assistance, your call
will be connected with an on-duty
Client Services Representative.

©2018 Genoptix, Inc. All rights reserved.
  • Legal
  • Pay My Bill
Scroll to top